DLB vs MRK · P/E 28, rev $1.35B vs P/E 33, rev $16.61B
Dolby Laboratories (DLB) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Dolby Laboratories (DLB) is a specialty business services company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported DLB revenue for 2025-09-26 was $1.35B. Net income was $256.5M. DLB currently screens at market cap $7.19B and trailing P/E 28.3.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
DLB currently screens at market cap $7.19B and trailing P/E 28.3. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the DLB and MRK stock pages for the full models.
Not investment advice.